Shares of Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) fell 6.3% during trading on Monday after an insider sold shares in the company. The company traded as low as $123.17 and last traded at $123.6040. 12,883 shares were traded during trading, a decline of 97% from the average session volume of 368,967 shares. The stock had previously closed at $131.89.
Specifically, CEO Stephen W. Beard sold 2,529 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $130.78, for a total transaction of $330,742.62. Following the sale, the chief executive officer directly owned 424,033 shares in the company, valued at $55,455,035.74. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 2,762 shares of the stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $130.14, for a total value of $359,446.68. Following the transaction, the chief executive officer owned 426,562 shares of the company’s stock, valued at approximately $55,512,778.68. The trade was a 0.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the stock. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Truist Financial upped their target price on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Finally, Barrington Research reiterated an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research note on Monday, June 8th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Adtalem Global Education has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.
Adtalem Global Education Stock Performance
The stock’s fifty day moving average price is $120.70. The firm has a market capitalization of $4.25 billion, a PE ratio of 19.40, a P/E/G ratio of 1.07 and a beta of 0.62. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36.
Adtalem Global Education (NYSE:CVSA – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, equities research analysts forecast that Adtalem Global Education Inc. will post 8.04 earnings per share for the current year.
About Adtalem Global Education
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Further Reading
- Five stocks we like better than Adtalem Global Education
- Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
- Mission Control: Floating In SpaceX’s Record-Breaking Orbit
- Forget AI for a Moment, This Homebuilder Is Stealing the Show
- Qualcomm Drops 25%, But Investor Day Could Reverse the Slide
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
